Peptide API Manufacturing Enters a New Era of Innovation and Global Expansion

The global pharmaceutical industry is witnessing a significant transformation driven by advances in Peptide API Manufacturing. As peptide-based therapeutics gain traction in treating chronic diseases such as diabetes, obesity, and cancer, demand for high-quality peptide active pharmaceutical ingredients continues to surge. This trend is reshaping the landscape of Peptide API Manufacturing, pushing contract development and manufacturing organizations (CDMOs) to innovate and scale rapidly to handle this increasing demand.

2026-04-16

Topical Formulation CDMO Gains Momentum as Demand for Advanced Drug Delivery Surges

The global pharmaceutical outsourcing landscape is witnessing rapid transformation, with Topical Formulation CDMO services emerging as a key growth engine. As demand for dermatological and localized therapies continues to rise, Topical Formulation CDMO providers are playing an increasingly strategic role in accelerating drug development and commercialization.

2026-04-09

BIO KOREA 2026

Date: 28–30 April 2026 Venue: COEX Convention & Exhibition Center, Seoul, South Korea

2026-04-02

Anglonordic Life Science Conference 2026

Date: 23 April 2026 Venue: County Hall, London, UK

2026-04-02

CPHI Japan 2026

Date: 21–23 April 2026 Venue: Tokyo Big Sight (Tokyo International Exhibition Center), Tokyo, Japan Jiuzhou Booth: 3C-04

2026-04-02

American Association for Cancer Research (AACR)

Date: 17–21 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA

2026-04-02

German Biotech Day 2026

Date: 21–22 April 2026 Venue: Kongresshalle am Zoo, Leipzig, Germany

2026-04-02

42nd SCI Process Development Symposium 2026

Date: 15–17 April 2026 Venue: Churchill College, University of Cambridge, Cambridge, UK

2026-04-02

Drug Discovery Chemistry 2026

Date: 13–16 April 2026 Venue: San Diego Convention Center, San Diego, CA, USA

2026-04-02

inCosmetics global

Date: 14–16 April 2026 Venue: Paris Expo Porte de Versailles, Paris, France

2026-04-02

Fluorine Chemistry CDMO Accelerates Innovation in Global Pharmaceutical Development

The rapid evolution of the pharmaceutical industry is driving increasing demand for specialized services such as Fluorine Chemistry, a niche yet critical segment supporting the development of advanced drug molecules.

2026-04-02

< 1234...9 >

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us




[Multiple]Interested business area:
Small Molecule CDMO Services
CDMO-Preparations
CDMO-Polypeptide
Generic drug Service
Registration & Regulatory Service
Animal Health Services